HIV ATLAS

Social Media for HIV, TB & Malaria!

English Afrikaans Albanian Arabic Armenian Azerbaijani Basque Belarusian Bulgarian Catalan Chinese (Simplified) Chinese (Traditional) Croatian Czech Danish Dutch Estonian Filipino Finnish French Galician Georgian German Greek Haitian Creole Hebrew Hindi Hungarian Icelandic Indonesian Irish Italian Japanese Korean Latvian Lithuanian Macedonian Malay Maltese Norwegian Persian Polish Portuguese Romanian Russian Serbian Slovak Slovenian Spanish Swahili Swedish Thai Turkish Ukrainian Urdu Vietnamese Welsh Yiddish

Programmed death-1-induced interleukin-10 production by monocytes impairs CD4(+) T cell activation during HIV infection.

Programmed death-1-induced interleukin-10 production by monocytes impairs CD4(+) T cell activation during HIV infection. - Related Articles
Programmed death-1-induced interleukin-10 production by monocytes impairs CD4(+) T cell activation during HIV infection.
Nat Med. 2010 Mar 7;
Authors: Said EA, Dupuy FP, Trautmann L, Zhang Y, Shi Y, El-Far M, Hill BJ, Noto A, Ancuta P, Peretz Y, Fonseca SG, Van Grevenynghe J, Boulassel MR, Bruneau J, Shoukry NH, Routy JP, Douek DC, Haddad EK, Sekaly RP
Viral replication and microbial translocation from the gut to the blood during HIV infection lead to hyperimmune activation, which contributes to the decline in CD4(+) T cell numbers during HIV infection. Programmed death-1 (PD-1) and interleukin-10 (IL-10) are both upregulated during HIV infection. Blocking interactions between PD-1 and programmed death ligand-1 (PD-L1) and between IL-10 and IL-10 receptor (IL-10R) results in viral clearance and improves T cell function in animal models of chronic viral infections. Here we show that high amounts of microbial products and inflammatory cytokines in the plasma of HIV-infected subjects lead to upregulation of PD-1 expression on monocytes that correlates with high plasma concentrations of IL-10. Triggering of PD-1 expressed on monocytes by PD-L1 expressed on various cell types induced IL-10 production and led to reversible CD4(+) T cell dysfunction. We describe a new function for PD-1 whereby microbial products inhibit T cell expansion and function by upregulating PD-1 levels and IL-10 production by monocytes after binding of PD-1 by PD-L1.
PMID: 20208540 [PubMed - as supplied by publisher]
[PubMed-HIV]

By jenna - Posted on 10 March 2010 Share this

HIV ATLAS

Job Central

Classified Blogs

Event Central

Classified Ads

IEC Central

Videos

Resources

Monthly archive

Latest Jobs (Weekly)

Stay informed on our latest news!

Syndicate content

Classified Resources